The Safety and Efficacy of Approved Biologic Therapies for Hidradenitis Suppurativa: A Systematic Review and Network Meta-Analysis

Published: 29 July 2025| Version 1 | DOI: 10.17632/n96m946h86.1
Contributors:
Emmanuel Suntres, Daud Manzar, Raed Alhusayen

Description

To systematically quantify the safety and efficacy of approved biologic therapies in patients with hidradenitis suppurativa (HS). A PRISMA flow diagram, Funnel plot, Forest plot, Search Strategy, Extraction Data, PRISMA 2020 checklist and summary table, Network Plot, were created as supplemental material to be auxiliary to our systematic review and meta-analysis.

Files

Institutions

  • Sunnybrook Health Sciences Centre
  • McMaster University Michael G DeGroote School of Medicine
  • University of Toronto

Categories

Dermatology, Biologic Agent, Tumor Necrosis Factor, Interleukin-17 Family, Hidradenitis Suppurativa

Licence